[1] |
Youlden DR, Baade PD, Walker R, et al. Breast cancer incidence and survival among young females in Queensland, Australia[J]. J Adolesc Young Adult Oncol, 2020, 9(3):402-409. DOI: 10.1089/jayao.2019.0119.
doi: 10.1089/jayao.2019.0119
|
[2] |
Zuo TT, Zheng RS, Zeng HM, et al. Female breast cancer incidence and mortality in China, 2013[J]. Thorac Cancer, 2017, 8(3):214-218. DOI: 10.1111/1759-7714.12426.
doi: 10.1111/tca.2017.8.issue-3
|
[3] |
Sun YS, Zhao Z, Yang ZN, et al. Risk factors and preventions of breast cancer[J]. Int J Biol Sci, 2017, 13(11):1387-1397. DOI: 10.7150/ijbs.21635.
doi: 10.7150/ijbs.21635
|
[4] |
Duchartre Y, Kim YM, Kahn M. The Wnt signaling pathway in cancer[J]. Crit Rev Oncol Hematol, 2016, 99:141-149. DOI: 10.1016/j.critrevonc.2015.12.005.
doi: 10.1016/j.critrevonc.2015.12.005
|
[5] |
Li K, Zhang J, Tian Y, et al. The Wnt/β-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer[J]. Oncogene, 2020, 39(11):2258-2274. DOI: 10.1038/s41388-019-1145-3.
doi: 10.1038/s41388-019-1145-3
|
[6] |
Rattanaburee T, Tipmanee V, Tedasen A, et al. Inhibition of CSF1R and AKT by (±)-kusunokinin hinders breast cancer cell proliferation[J]. Biomed Pharmacothe, 2020, 129:110361. DOI: 10.1016/j.biopha.2020.110361.
|
[7] |
Huang J, Lu T, Kuang W. Prognostic role of dickkopf-1 in patients with cancer[J]. Medicine, 2020, 99(21):e20388. DOI: 10.1097/MD.0000000000020388.
doi: 10.1097/MD.0000000000020388
|
[8] |
曹亮. 免疫组化五项指标(PSA、PAP、HCK、P63、AMACR)的表达在前列腺病变诊断中的应用价值[D]. 长沙: 中南大学, 2010. DOI: 10.7666/d.y1720743.
|
[9] |
陈冬华, 李强, 周浩, 等. 上海市农村妇女乳腺疾病谱及影响因素研究[J]. 中国初级卫生保健, 2013, 27(12):48-49. DOI: 10.3969/j.issn.1001-568X.2013.12.0018.
|
[10] |
Liu S, Wang Z, Liu Z, et al. miR-221/222 activate the Wnt/β-catenin signaling to promote triple negative breast cancer[J]. J Mol Cell Biol, 2018, 10(4):302-315. DOI: 10.1093/jmcb/mjy041.
doi: 10.1093/jmcb/mjy041
|
[11] |
Taciak B, Pruszynska I, Kiraga L, et al. Wnt signaling pathway in development and cancer[J]. J Physiol Pharmacol, 2018, 69(2):185-196. DOI: 10.26402/jpp.2018.2.07.
doi: 10.1139/y91-027
|
[12] |
Shang S, Hua F, Hu ZW. The regulation of β-catenin activity and function in cancer: therapeutic opportunities[J]. Oncotarget, 2017, 8(20):33972-33989. DOI: 10.18632/oncotarget.15687.
doi: 10.18632/oncotarget.v8i20
|
[13] |
杨红敏. 乳腺癌中Wnt信号通路关键因子β-catenin的突变和表达研究[J]. 数理医药学杂志, 2019, 32(8):1124-1126. DOI: 10.3969/j.issn.1004-4337.2019.08.008.
|
[14] |
Pandey A, Bahl C, Sharma S, et al. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients[J]. Tumori, 2018, 104(3):179-187.DOI: 10.1177/0300891617753477.
doi: 10.1177/0300891617753477
|
[15] |
Feng ZY, Xu XH, Cen DZ, et al. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1[J]. Eur Rev Med Pharmacol Sci, 2017, 21(21):4844-4852.
|
[16] |
Ni D, Yi Q, Liu J, et al. A1CF-promoted colony formation and proliferation of RCC depends on DKK1-MEK/ERK signal axis[J]. Gene, 2020, 730:144299. DOI: 10.1016/j.gene.2019.144299.
doi: 10.1016/j.gene.2019.144299
|
[17] |
陆鸿略, 张淑君, 岳文慧, 等. Dkk-1及Bcl-2蛋白在人鼻腔鼻窦鳞状细胞癌中的表达及意义[J]. 重庆医学, 2015, 44(12):1652-1654, 1657. DOI: 10.3969/j.issn.1671-8348.2015.12.023.
|
[18] |
潘理会, 李春辉, 佟晓波, 等. Wnt信号通路的组件蛋白DKK-1、β-catenin及CyclinD1在胃癌中的表达与相互关系[J]. 实用医学杂志, 2013, 29(15):2517-2519. DOI: 10.3969/j.issn.1006-5725.2013.15.037.
|
[19] |
Ren L, Chen H, Song J, et al. MiR-454-3p-mediated Wnt/β-catenin signaling antagonists suppression promotes breast cancer metastasis[J]. Theranostics, 2019, 9(2):449-465. DOI: 10.7150/thno.29055.
doi: 10.7150/thno.29055
|
[20] |
Zhuang X, Zhang H, Li X, et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1[J]. Nat Cell Biol, 2017, 19(10):1274-1285. DOI: 10.1038/ncb3613.
doi: 10.1038/ncb3613
|